Thyroid cancer
Results
Phase 3
This trial looked cabozantinib (also called XL184) for medullary thyroid cancer that has spread outside the thyroid gland and cannot be removed with surgery.
Recruitment start: 1 September 2008
Recruitment end: 28 February 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Nick Reed
Exelixis
NIHR Clinical Research Network: Cancer
Last reviewed: 9 August 2016
CRUK internal database number: 606
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
